Interaction Between Aspirin and ACE Inhibitors View Full Text


Ontology type: schema:ScholarlyArticle     


Article Info

DATE

2002-04

AUTHORS

Bahi Takkouche, Mahyar Etminan, Francisco Caamaño, Paula A. Rochon

ABSTRACT

BACKGROUND: Recently, studies have attempted to explore the interaction between ACE inhibitors and aspirin (acetylsalicylic acid) when both drugs are used concomitantly to reduce mortality in patients with coronary artery disease. Results have been conflicting due, in part, to sub-optimal methods used to explore this interaction. METHODS: We reviewed systematically all studies on mortality in patients treated with ACE inhibitors and aspirin and conducted a meta-analysis in order to explore the interaction between both drugs and resolve discrepancies. To be included, each study had to provide data on mortality of patients who received both drugs, either drug and no drug. These data were necessary to calculate the synergy index (S) and its 95% confidence interval (CI) that we used to quantify the effect due to interaction between ACE inhibitors and aspirin. After testing for heterogeneity of effects, we pooled the S values from the individual studies into one summary measure. Subsequently, we compared our results with those obtained through the most common but incorrect method of evaluating interaction. This method uses significance testing of the relative risk of mortality when a 'product term' between ACE inhibitors and aspirin is entered in a logistic regression model. RESULTS: Eight studies met the inclusion criteria. The pooled synergy index S indicates slight but precise antagonism between ACE inhibitors and aspirin (S = 0.91; 95% CI 0.80 to 1.03). In contrast, the pooled 'product term' is not significant and would have lead to the conclusion of absence of interaction (p = 0.15). CONCLUSION: There seems to be an antagonistic interaction between ACE inhibitors and aspirin. Former discrepancies were due to inadequate assessment of interaction. Results from the Studies on Left Ventricular Dysfunction (SOLVD) and Heart Outcome Prevention Evaluation (HOPE) trials that assessed the effect of combined administration of ACE inhibitors and aspirin were not included in this meta-analysis because those trials did not provide enough data to compute the S statistic. It is possible that results from on-going trials such as Women's Atovarstatin Trial on Cholesterol (WATCH) will shed more light on ACE inhibitor and aspirin interaction in the future. More... »

PAGES

373-378

References to SciGraph publications

Identifiers

URI

http://scigraph.springernature.com/pub.10.2165/00002018-200225050-00005

DOI

http://dx.doi.org/10.2165/00002018-200225050-00005

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1051947331

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/12020174


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1117", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Public Health and Health Services", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Angiotensin-Converting Enzyme Inhibitors", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Aspirin", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Coronary Artery Disease", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Drug Interactions", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Drug Therapy, Combination", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Humans", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Meta-Analysis as Topic", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "University of Santiago de Compostela", 
          "id": "https://www.grid.ac/institutes/grid.11794.3a", 
          "name": [
            "Department of Preventive Medicine, University of Santiago de Compostela, Area de Medicina Preventiva, Facultad de Medicina, C/San Francisco s/n, 15705, Santiago de Compostela, Spain"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Takkouche", 
        "givenName": "Bahi", 
        "id": "sg:person.01161765574.42", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01161765574.42"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "University of Toronto", 
          "id": "https://www.grid.ac/institutes/grid.17063.33", 
          "name": [
            "Kunin-Lunenfeld Applied Research Unit, Department of Clinical Epidemiology, Baycrest Center for Geriatric Care, University of Toronto, Toronto, Ontario, Canada"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Etminan", 
        "givenName": "Mahyar", 
        "id": "sg:person.0777312127.85", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0777312127.85"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "University of Santiago de Compostela", 
          "id": "https://www.grid.ac/institutes/grid.11794.3a", 
          "name": [
            "Department of Preventive Medicine, University of Santiago de Compostela, Area de Medicina Preventiva, Facultad de Medicina, C/San Francisco s/n, 15705, Santiago de Compostela, Spain"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Caama\u00f1o", 
        "givenName": "Francisco", 
        "id": "sg:person.0742405722.14", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0742405722.14"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "University of Toronto", 
          "id": "https://www.grid.ac/institutes/grid.17063.33", 
          "name": [
            "Kunin-Lunenfeld Applied Research Unit, Baycrest Centre for Geriatric Care; Departments of Medicine and Public Health Sciences, Faculty of Medicine, University of Toronto, Institute for Clinical Evaluative Sciences, Sunnybrook and Women\u2019s College Health Sciences Centre, Toronto, Ontario, Canada"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Rochon", 
        "givenName": "Paula A.", 
        "id": "sg:person.01005772611.81", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01005772611.81"
        ], 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "https://doi.org/10.1056/nejm199501123320203", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1002958815"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s0735-1097(99)00129-1", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1004812167"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s0140-6736(00)02212-1", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1006046161"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1161/01.cir.100.9.1016", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1012948362"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/0140-6736(93)92693-n", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1013069144"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/0140-6736(93)92693-n", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1013069144"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1056/nejm199108013250501", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1013210498"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s0002-9343(00)00492-7", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1014811047"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1056/nejm199512213332503", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1025734830"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s0140-6736(95)90866-8", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1027264795"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s0140-6736(95)90866-8", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1027264795"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1056/nejm199209033271002", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1036005063"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.2165/00002018-200124030-00002", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1037493090", 
          "https://doi.org/10.2165/00002018-200124030-00002"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.2165/00002018-200124030-00002", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1037493090", 
          "https://doi.org/10.2165/00002018-200124030-00002"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s0735-1097(00)00638-0", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1040855815"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1093/oxfordjournals.aje.a009981", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1042600360"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s0140-6736(95)90865-x", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1042800449"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s0140-6736(95)90865-x", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1042800449"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1093/bmb/59.1.135", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1046989474"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s0002-9149(96)00696-0", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1047122365"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1001/archinte.161.4.538", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1047314143"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1046/j.1365-2796.1996.431782000.x", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1047587573"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s0735-1097(97)00502-0", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1048823167"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1056/nejm200001203420301", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1050329362"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1001/archinte.160.10.1409", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1051987843"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1056/nejm199209033271001", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1053464475"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1001/archinte.161.16.2048", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1054116037"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1093/oxfordjournals.aje.a112252", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1075286946"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://app.dimensions.ai/details/publication/pub.1082561405", 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2002-04", 
    "datePublishedReg": "2002-04-01", 
    "description": "BACKGROUND: Recently, studies have attempted to explore the interaction between ACE inhibitors and aspirin (acetylsalicylic acid) when both drugs are used concomitantly to reduce mortality in patients with coronary artery disease. Results have been conflicting due, in part, to sub-optimal methods used to explore this interaction.\nMETHODS: We reviewed systematically all studies on mortality in patients treated with ACE inhibitors and aspirin and conducted a meta-analysis in order to explore the interaction between both drugs and resolve discrepancies. To be included, each study had to provide data on mortality of patients who received both drugs, either drug and no drug. These data were necessary to calculate the synergy index (S) and its 95% confidence interval (CI) that we used to quantify the effect due to interaction between ACE inhibitors and aspirin. After testing for heterogeneity of effects, we pooled the S values from the individual studies into one summary measure. Subsequently, we compared our results with those obtained through the most common but incorrect method of evaluating interaction. This method uses significance testing of the relative risk of mortality when a 'product term' between ACE inhibitors and aspirin is entered in a logistic regression model.\nRESULTS: Eight studies met the inclusion criteria. The pooled synergy index S indicates slight but precise antagonism between ACE inhibitors and aspirin (S = 0.91; 95% CI 0.80 to 1.03). In contrast, the pooled 'product term' is not significant and would have lead to the conclusion of absence of interaction (p = 0.15).\nCONCLUSION: There seems to be an antagonistic interaction between ACE inhibitors and aspirin. Former discrepancies were due to inadequate assessment of interaction. Results from the Studies on Left Ventricular Dysfunction (SOLVD) and Heart Outcome Prevention Evaluation (HOPE) trials that assessed the effect of combined administration of ACE inhibitors and aspirin were not included in this meta-analysis because those trials did not provide enough data to compute the S statistic. It is possible that results from on-going trials such as Women's Atovarstatin Trial on Cholesterol (WATCH) will shed more light on ACE inhibitor and aspirin interaction in the future.", 
    "genre": "research_article", 
    "id": "sg:pub.10.2165/00002018-200225050-00005", 
    "inLanguage": [
      "en"
    ], 
    "isAccessibleForFree": false, 
    "isPartOf": [
      {
        "id": "sg:journal.1096281", 
        "issn": [
          "0114-5916", 
          "1179-1942"
        ], 
        "name": "Drug Safety", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "5", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "25"
      }
    ], 
    "name": "Interaction Between Aspirin and ACE Inhibitors", 
    "pagination": "373-378", 
    "productId": [
      {
        "name": "readcube_id", 
        "type": "PropertyValue", 
        "value": [
          "f77243fe2599fa9359e201f49ec282a4b768ba49e22660512435919a936e06c6"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "12020174"
        ]
      }, 
      {
        "name": "nlm_unique_id", 
        "type": "PropertyValue", 
        "value": [
          "9002928"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.2165/00002018-200225050-00005"
        ]
      }, 
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1051947331"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.2165/00002018-200225050-00005", 
      "https://app.dimensions.ai/details/publication/pub.1051947331"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2019-04-11T12:40", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-uberresearch-data-dimensions-target-20181106-alternative/cleanup/v134/2549eaecd7973599484d7c17b260dba0a4ecb94b/merge/v9/a6c9fde33151104705d4d7ff012ea9563521a3ce/jats-lookup/v90/0000000363_0000000363/records_70049_00000002.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "http://link.springer.com/10.2165/00002018-200225050-00005"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.2165/00002018-200225050-00005'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.2165/00002018-200225050-00005'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.2165/00002018-200225050-00005'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.2165/00002018-200225050-00005'


 

This table displays all metadata directly associated to this object as RDF triples.

197 TRIPLES      21 PREDICATES      61 URIs      28 LITERALS      16 BLANK NODES

Subject Predicate Object
1 sg:pub.10.2165/00002018-200225050-00005 schema:about N313e7c7e3d134bd9b5abf943bcdebd25
2 N4abc024366884566a08210e9f68b900a
3 N9280832922384ad493cda99ad3bfe28b
4 N9d901fe36a4b4f4db687b2b4142a8dcb
5 Naf6daa37967340b494ed7ad2c90e74b0
6 Ncb3f5466ecbd4492adb0c058744daea2
7 Nd805df4755e649ea995a57422d477684
8 anzsrc-for:11
9 anzsrc-for:1117
10 schema:author Na2ea640cf5584e72b3f348fce50d4ce3
11 schema:citation sg:pub.10.2165/00002018-200124030-00002
12 https://app.dimensions.ai/details/publication/pub.1082561405
13 https://doi.org/10.1001/archinte.160.10.1409
14 https://doi.org/10.1001/archinte.161.16.2048
15 https://doi.org/10.1001/archinte.161.4.538
16 https://doi.org/10.1016/0140-6736(93)92693-n
17 https://doi.org/10.1016/s0002-9149(96)00696-0
18 https://doi.org/10.1016/s0002-9343(00)00492-7
19 https://doi.org/10.1016/s0140-6736(00)02212-1
20 https://doi.org/10.1016/s0140-6736(95)90865-x
21 https://doi.org/10.1016/s0140-6736(95)90866-8
22 https://doi.org/10.1016/s0735-1097(00)00638-0
23 https://doi.org/10.1016/s0735-1097(97)00502-0
24 https://doi.org/10.1016/s0735-1097(99)00129-1
25 https://doi.org/10.1046/j.1365-2796.1996.431782000.x
26 https://doi.org/10.1056/nejm199108013250501
27 https://doi.org/10.1056/nejm199209033271001
28 https://doi.org/10.1056/nejm199209033271002
29 https://doi.org/10.1056/nejm199501123320203
30 https://doi.org/10.1056/nejm199512213332503
31 https://doi.org/10.1056/nejm200001203420301
32 https://doi.org/10.1093/bmb/59.1.135
33 https://doi.org/10.1093/oxfordjournals.aje.a009981
34 https://doi.org/10.1093/oxfordjournals.aje.a112252
35 https://doi.org/10.1161/01.cir.100.9.1016
36 schema:datePublished 2002-04
37 schema:datePublishedReg 2002-04-01
38 schema:description BACKGROUND: Recently, studies have attempted to explore the interaction between ACE inhibitors and aspirin (acetylsalicylic acid) when both drugs are used concomitantly to reduce mortality in patients with coronary artery disease. Results have been conflicting due, in part, to sub-optimal methods used to explore this interaction. METHODS: We reviewed systematically all studies on mortality in patients treated with ACE inhibitors and aspirin and conducted a meta-analysis in order to explore the interaction between both drugs and resolve discrepancies. To be included, each study had to provide data on mortality of patients who received both drugs, either drug and no drug. These data were necessary to calculate the synergy index (S) and its 95% confidence interval (CI) that we used to quantify the effect due to interaction between ACE inhibitors and aspirin. After testing for heterogeneity of effects, we pooled the S values from the individual studies into one summary measure. Subsequently, we compared our results with those obtained through the most common but incorrect method of evaluating interaction. This method uses significance testing of the relative risk of mortality when a 'product term' between ACE inhibitors and aspirin is entered in a logistic regression model. RESULTS: Eight studies met the inclusion criteria. The pooled synergy index S indicates slight but precise antagonism between ACE inhibitors and aspirin (S = 0.91; 95% CI 0.80 to 1.03). In contrast, the pooled 'product term' is not significant and would have lead to the conclusion of absence of interaction (p = 0.15). CONCLUSION: There seems to be an antagonistic interaction between ACE inhibitors and aspirin. Former discrepancies were due to inadequate assessment of interaction. Results from the Studies on Left Ventricular Dysfunction (SOLVD) and Heart Outcome Prevention Evaluation (HOPE) trials that assessed the effect of combined administration of ACE inhibitors and aspirin were not included in this meta-analysis because those trials did not provide enough data to compute the S statistic. It is possible that results from on-going trials such as Women's Atovarstatin Trial on Cholesterol (WATCH) will shed more light on ACE inhibitor and aspirin interaction in the future.
39 schema:genre research_article
40 schema:inLanguage en
41 schema:isAccessibleForFree false
42 schema:isPartOf Nee678ae3998a42f693e02b115407c6c5
43 Nf3fde191cf7e42acb0b2fb77324e64bc
44 sg:journal.1096281
45 schema:name Interaction Between Aspirin and ACE Inhibitors
46 schema:pagination 373-378
47 schema:productId N080a075a898f477cbdfd87c782efddd6
48 N4ef910ef26394dfdac6cc0dc5dd320a5
49 N6a054aca4fab4119bd76a44099f25122
50 N7091559ac8624a27b6d9c4ad04de810b
51 Nf7a56be8c6d548fb87740f04ce5ea46d
52 schema:sameAs https://app.dimensions.ai/details/publication/pub.1051947331
53 https://doi.org/10.2165/00002018-200225050-00005
54 schema:sdDatePublished 2019-04-11T12:40
55 schema:sdLicense https://scigraph.springernature.com/explorer/license/
56 schema:sdPublisher N45a22a875c50408f923dda3cef7cb0e6
57 schema:url http://link.springer.com/10.2165/00002018-200225050-00005
58 sgo:license sg:explorer/license/
59 sgo:sdDataset articles
60 rdf:type schema:ScholarlyArticle
61 N080a075a898f477cbdfd87c782efddd6 schema:name dimensions_id
62 schema:value pub.1051947331
63 rdf:type schema:PropertyValue
64 N313e7c7e3d134bd9b5abf943bcdebd25 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
65 schema:name Aspirin
66 rdf:type schema:DefinedTerm
67 N45a22a875c50408f923dda3cef7cb0e6 schema:name Springer Nature - SN SciGraph project
68 rdf:type schema:Organization
69 N4abc024366884566a08210e9f68b900a schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
70 schema:name Angiotensin-Converting Enzyme Inhibitors
71 rdf:type schema:DefinedTerm
72 N4ef910ef26394dfdac6cc0dc5dd320a5 schema:name doi
73 schema:value 10.2165/00002018-200225050-00005
74 rdf:type schema:PropertyValue
75 N531b2a36b7ae4907936cc328138ca32b rdf:first sg:person.01005772611.81
76 rdf:rest rdf:nil
77 N6a054aca4fab4119bd76a44099f25122 schema:name readcube_id
78 schema:value f77243fe2599fa9359e201f49ec282a4b768ba49e22660512435919a936e06c6
79 rdf:type schema:PropertyValue
80 N7091559ac8624a27b6d9c4ad04de810b schema:name pubmed_id
81 schema:value 12020174
82 rdf:type schema:PropertyValue
83 N7f71f4fd49fa48fbae7a1ae670e7fb54 rdf:first sg:person.0777312127.85
84 rdf:rest N8385074ea05a42dcbe9cdb0537e36e5e
85 N8385074ea05a42dcbe9cdb0537e36e5e rdf:first sg:person.0742405722.14
86 rdf:rest N531b2a36b7ae4907936cc328138ca32b
87 N9280832922384ad493cda99ad3bfe28b schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
88 schema:name Coronary Artery Disease
89 rdf:type schema:DefinedTerm
90 N9d901fe36a4b4f4db687b2b4142a8dcb schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
91 schema:name Drug Therapy, Combination
92 rdf:type schema:DefinedTerm
93 Na2ea640cf5584e72b3f348fce50d4ce3 rdf:first sg:person.01161765574.42
94 rdf:rest N7f71f4fd49fa48fbae7a1ae670e7fb54
95 Naf6daa37967340b494ed7ad2c90e74b0 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
96 schema:name Meta-Analysis as Topic
97 rdf:type schema:DefinedTerm
98 Ncb3f5466ecbd4492adb0c058744daea2 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
99 schema:name Drug Interactions
100 rdf:type schema:DefinedTerm
101 Nd805df4755e649ea995a57422d477684 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
102 schema:name Humans
103 rdf:type schema:DefinedTerm
104 Nee678ae3998a42f693e02b115407c6c5 schema:volumeNumber 25
105 rdf:type schema:PublicationVolume
106 Nf3fde191cf7e42acb0b2fb77324e64bc schema:issueNumber 5
107 rdf:type schema:PublicationIssue
108 Nf7a56be8c6d548fb87740f04ce5ea46d schema:name nlm_unique_id
109 schema:value 9002928
110 rdf:type schema:PropertyValue
111 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
112 schema:name Medical and Health Sciences
113 rdf:type schema:DefinedTerm
114 anzsrc-for:1117 schema:inDefinedTermSet anzsrc-for:
115 schema:name Public Health and Health Services
116 rdf:type schema:DefinedTerm
117 sg:journal.1096281 schema:issn 0114-5916
118 1179-1942
119 schema:name Drug Safety
120 rdf:type schema:Periodical
121 sg:person.01005772611.81 schema:affiliation https://www.grid.ac/institutes/grid.17063.33
122 schema:familyName Rochon
123 schema:givenName Paula A.
124 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01005772611.81
125 rdf:type schema:Person
126 sg:person.01161765574.42 schema:affiliation https://www.grid.ac/institutes/grid.11794.3a
127 schema:familyName Takkouche
128 schema:givenName Bahi
129 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01161765574.42
130 rdf:type schema:Person
131 sg:person.0742405722.14 schema:affiliation https://www.grid.ac/institutes/grid.11794.3a
132 schema:familyName Caamaño
133 schema:givenName Francisco
134 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0742405722.14
135 rdf:type schema:Person
136 sg:person.0777312127.85 schema:affiliation https://www.grid.ac/institutes/grid.17063.33
137 schema:familyName Etminan
138 schema:givenName Mahyar
139 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0777312127.85
140 rdf:type schema:Person
141 sg:pub.10.2165/00002018-200124030-00002 schema:sameAs https://app.dimensions.ai/details/publication/pub.1037493090
142 https://doi.org/10.2165/00002018-200124030-00002
143 rdf:type schema:CreativeWork
144 https://app.dimensions.ai/details/publication/pub.1082561405 schema:CreativeWork
145 https://doi.org/10.1001/archinte.160.10.1409 schema:sameAs https://app.dimensions.ai/details/publication/pub.1051987843
146 rdf:type schema:CreativeWork
147 https://doi.org/10.1001/archinte.161.16.2048 schema:sameAs https://app.dimensions.ai/details/publication/pub.1054116037
148 rdf:type schema:CreativeWork
149 https://doi.org/10.1001/archinte.161.4.538 schema:sameAs https://app.dimensions.ai/details/publication/pub.1047314143
150 rdf:type schema:CreativeWork
151 https://doi.org/10.1016/0140-6736(93)92693-n schema:sameAs https://app.dimensions.ai/details/publication/pub.1013069144
152 rdf:type schema:CreativeWork
153 https://doi.org/10.1016/s0002-9149(96)00696-0 schema:sameAs https://app.dimensions.ai/details/publication/pub.1047122365
154 rdf:type schema:CreativeWork
155 https://doi.org/10.1016/s0002-9343(00)00492-7 schema:sameAs https://app.dimensions.ai/details/publication/pub.1014811047
156 rdf:type schema:CreativeWork
157 https://doi.org/10.1016/s0140-6736(00)02212-1 schema:sameAs https://app.dimensions.ai/details/publication/pub.1006046161
158 rdf:type schema:CreativeWork
159 https://doi.org/10.1016/s0140-6736(95)90865-x schema:sameAs https://app.dimensions.ai/details/publication/pub.1042800449
160 rdf:type schema:CreativeWork
161 https://doi.org/10.1016/s0140-6736(95)90866-8 schema:sameAs https://app.dimensions.ai/details/publication/pub.1027264795
162 rdf:type schema:CreativeWork
163 https://doi.org/10.1016/s0735-1097(00)00638-0 schema:sameAs https://app.dimensions.ai/details/publication/pub.1040855815
164 rdf:type schema:CreativeWork
165 https://doi.org/10.1016/s0735-1097(97)00502-0 schema:sameAs https://app.dimensions.ai/details/publication/pub.1048823167
166 rdf:type schema:CreativeWork
167 https://doi.org/10.1016/s0735-1097(99)00129-1 schema:sameAs https://app.dimensions.ai/details/publication/pub.1004812167
168 rdf:type schema:CreativeWork
169 https://doi.org/10.1046/j.1365-2796.1996.431782000.x schema:sameAs https://app.dimensions.ai/details/publication/pub.1047587573
170 rdf:type schema:CreativeWork
171 https://doi.org/10.1056/nejm199108013250501 schema:sameAs https://app.dimensions.ai/details/publication/pub.1013210498
172 rdf:type schema:CreativeWork
173 https://doi.org/10.1056/nejm199209033271001 schema:sameAs https://app.dimensions.ai/details/publication/pub.1053464475
174 rdf:type schema:CreativeWork
175 https://doi.org/10.1056/nejm199209033271002 schema:sameAs https://app.dimensions.ai/details/publication/pub.1036005063
176 rdf:type schema:CreativeWork
177 https://doi.org/10.1056/nejm199501123320203 schema:sameAs https://app.dimensions.ai/details/publication/pub.1002958815
178 rdf:type schema:CreativeWork
179 https://doi.org/10.1056/nejm199512213332503 schema:sameAs https://app.dimensions.ai/details/publication/pub.1025734830
180 rdf:type schema:CreativeWork
181 https://doi.org/10.1056/nejm200001203420301 schema:sameAs https://app.dimensions.ai/details/publication/pub.1050329362
182 rdf:type schema:CreativeWork
183 https://doi.org/10.1093/bmb/59.1.135 schema:sameAs https://app.dimensions.ai/details/publication/pub.1046989474
184 rdf:type schema:CreativeWork
185 https://doi.org/10.1093/oxfordjournals.aje.a009981 schema:sameAs https://app.dimensions.ai/details/publication/pub.1042600360
186 rdf:type schema:CreativeWork
187 https://doi.org/10.1093/oxfordjournals.aje.a112252 schema:sameAs https://app.dimensions.ai/details/publication/pub.1075286946
188 rdf:type schema:CreativeWork
189 https://doi.org/10.1161/01.cir.100.9.1016 schema:sameAs https://app.dimensions.ai/details/publication/pub.1012948362
190 rdf:type schema:CreativeWork
191 https://www.grid.ac/institutes/grid.11794.3a schema:alternateName University of Santiago de Compostela
192 schema:name Department of Preventive Medicine, University of Santiago de Compostela, Area de Medicina Preventiva, Facultad de Medicina, C/San Francisco s/n, 15705, Santiago de Compostela, Spain
193 rdf:type schema:Organization
194 https://www.grid.ac/institutes/grid.17063.33 schema:alternateName University of Toronto
195 schema:name Kunin-Lunenfeld Applied Research Unit, Baycrest Centre for Geriatric Care; Departments of Medicine and Public Health Sciences, Faculty of Medicine, University of Toronto, Institute for Clinical Evaluative Sciences, Sunnybrook and Women’s College Health Sciences Centre, Toronto, Ontario, Canada
196 Kunin-Lunenfeld Applied Research Unit, Department of Clinical Epidemiology, Baycrest Center for Geriatric Care, University of Toronto, Toronto, Ontario, Canada
197 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...